Grapiprant – a new drug for treating osteoarthritis in dogs

By doing this module you will:

  • understand the pharmacology of grapiprant;

  • know the clinical evidence on the efficacy and safety of grapiprant;

  • be aware of what is known about how grapiprant compares with NSAIDs;

  • understand what is meant by intention-to-treat and per-protocol analysis in clinical trials result analysis;

  • understand what is meant by the number needed to treat and its relevance to clinical practice.

Read More
Flea infestations - treating the environment

Many veterinary practices sell flea sprays or advise on their purchase for elimination of the environmental stages of a flea infestation. Several brands of flea spray are available, but some are being taken off the market (HSE 2018). 

By doing this module you will:

  • Understand the lifecycle of the cat flea.

  • Know the options available for treating a flea infestation.

  • Be aware of the evidence on the efficacy of environmental treatments.

  • Understand why some products are being taken off the market.

  • Know where to find out which products are authorised for sale.

Read More
Metronidazole neurotoxicity

Neurotoxicity is a recognised adverse effect of metronidazole, an antimicrobial used in cats and dogs to treat a variety of conditions. By doing this module you will:

  • Be aware of how metronidazole neurotoxicity can present in practice.

  • Understand what is known about the relationship between metronidazole dose and neurotoxicity.

  • Be aware of how to reduce the risk of neurotoxicity developing.

  • Know what you can do if it presents in practice.

Read More
Parasiticide Guide
  • includes all UK authorised parasiticides for cats dogs, ferrets and rabbits

  • search by parasite/disease, active ingredient(s), brand, species, formulation

  • updated every 3 months

  • find the product you need

Read More

By doing this module you will:

  • know what an NSAID is

  • understand the clinical pharmacology of NSAIDs

  • gain a broad understanding of the range of licensed uses of the different NSAIDs 

  • understand what is known about the comparative efficacy and safety of NSAIDs 

  • be able to make a rational choice.

Read More
Imported pets

By doing this module you will:

  • be aware of the parasitic diseases that may be found in an imported pet

  • know what clinical signs to look out for

  • be aware of the effective treatments, and how to get them

  • find out where to get further information and specialist advice.

Read More
Tramadol for pain relief in dogs: what's its place? (Updated)

By doing this module you will:

  • understand the pharmacology of tramadol

  • know the evidence on its efficacy in acute and chronic pain

  • be aware of the adverse effects

  • know the place of tramadol in the management of pain in dogs.

Read More
Handling veterinary medicines and pregnancy

By doing this module you will:

  • understand the principles of reproductive toxicity;

  • understand how data on the harmful effects of medicines are generated;

  • be aware of the evidence on reproductive harm in veterinary practice;

  • understand what practical measures to take to avoid harm;

  • know where to find helpful information on medicines and pregnancy.

Read More
Leptospira vaccines

By doing this module you will:

  • understand the naming system for Leptospira and the relevance to vaccination;

  • understand what is known about the types of Leptospira affecting dogs in the UK;

  • understand the features of the different vaccines and how they compare;

  • be aware of what is known about the safety of the vaccines';

  • be able to make a rational choice.

Read More
Amantadine in the management of chronic pain in dogs and cats

By doing this module you will:

  • Understand the pharmacology of amantadine and the rationale for using it in chronic pain.
  • Be aware of the published evidence on the use of amantadine in dogs and cats.
  • Find out what is known about the adverse effects of amantadine. 
  • Know the potential role of amantadine in the management of chronic pain and how to monitor its effects.
Read More
Taking pets abroad

By doing this module you will:

  • know the main parasite risks for pets visiting mainland Europe;

  • know where to find information about parasite distribution;

  • understand the drug and non-drug measures for reducing risk of infection

  • be able to make a rational choice of parasiticide products using the comprehensive table of products.

Read More
Prescribing veterinary specials

When a small animal needs a drug treatment, there is usually a licensed (authorised) medicine available, although it might be licensed for other species or indications. However, there are some circumstances when there is no suitable licensed product to fulfil a clinical need. To solve such a problem, it might be possible to use an unlicensed ‘special’ formulation. Specials are unlike licensed medicines because they are not assessed for safety or efficacy by a regulatory body. So vets must be satisfied there is sufficient evidence or experience to demonstrate safety and efficacy. Here we outline the facts and practical information relevant to prescribing special formulations.

Read More
What pet owners need to know about medicines

Much of an animal’s medical treatment will be administered by the owner at home. To do this safely and effectively, owners need information about why and how to use the treatments. This module discusses what sort of information owners need, what is required by law, what is available, and how it can be provided in the veterinary practice. 

Read More
Lipid emulsion in the management of toxicity

Intravenous lipid emulsion is increasingly being used as an adjunct in the management of toxicity caused by lipophilic drugs that are cardiotoxic (e.g. bupivacaine) or neurotoxic (e.g. permethrin). The Veterinary Poisons Information Service recommends that intravenous lipid emulsion be considered for any animal at risk of serious toxicity after exposure to a lipophilic compound (VPIS 2017). This module summarises what is known about this treatment, the uncertainties, and the practical aspects of using it. 

Read More
Lidocaine/prilocaine topical anaesthetic cream in small animals

Lidocaine (25mg/g) plus prilocaine (25mg/g) cream is a topical anaesthetic licensed for use in humans but not in animals. However, it is used in veterinary practice – for example, during venepuncture at the jugular or cephalic vein for blood sampling, especially in cats, or the ear veins in rabbits; and when inserting an intravenous cannula preoperatively in cats, dogs and rabbits. This module summarises the published evidence on the efficacy and safety of lidocaine/prilocaine cream in small animals, gives practical guidance on its use, and highlights the gaps in the evidence.

Read More
Lokivetmab – a new treatment for canine atopic dermatitis

Why do this module?

Lokivetmab is a new treatment for reducing the clinical signs of atopic dermatitis in dogs. It is also a new type of medicine (a monoclonal antibody) for the treatment of animals in the UK. This module explains about monoclonal antibodies, summarises what is known about the efficacy and safety of lokivetmab in the treatment of canine atopic dermatitis, and discusses where it might fit in the management of atopic dermatitis. 

Read More
Stem cell therapy for cats and dogs - not what you might expect.

When we last reviewed ‘stem cell’ therapy in 2014 there was only one small published clinical trial (in dogs with osteoarthritis) and this did not show a clear benefit. Now some veterinary practices offer ‘stem cell’ therapy for cats and dogs for the treatment of a wide range of conditions, including arthritis, hip dysplasia, tendinopathy, skin disease and inflammatory bowel disease. But how much has the evidence moved on? This module explains the forms of therapy available, why ‘stem cell’ therapy is now considered a misnomer, how the therapy is regulated, and what is known about its efficacy and safety in cats and dogs.

Read More
Drug interactions: understanding, predicting and managing them

There are many situations in which you might use several medicines at the same time in a companion animal – for example, to treat chronic diseases or multiple conditions in older animals; to achieve broad parasite protection; in anaesthetic protocols; and when anaesthetising animals on long-term drug treatment. 

This module covers: the principles of interactions and their potential consequences; interactions with herbal medicines and nutraceuticals; where to find information about interactions and what to do with it; and practical tips on predicting, avoiding and managing drug interactions.

Read More
Avoiding problems when stopping systemic glucocorticoid therapy

Glucocorticoids are widely used and are an important part of the veterinary therapeutic armoury. However, they cause well-known unwanted effects, including suppression of the hypothalamic-pituitary-adrenal axis (HPA axis), which can lead to problems when the treatment is stopped.This module outlines the rationale and evidence on steroid withdrawal in cats and dogs and includes an example of a withdrawal protocol. It was prompted by a query from a small-animal vet, who asked if there is a standard protocol for withdrawing steroid therapy.

Read More